Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection

This publication has 15 references indexed in Scilit:

• Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
  Journal of Antimicrobial Chemotherapy, 2012
• Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection
  International Journal of Antimicrobial Agents, 2012
• Mefloquine–oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113
  Bioorganic & Medicinal Chemistry, 2012
• In VitroandIn VivoEfficacies of Mefloquine-Based Treatment against Alveolar Echinococcosis
  Antimicrobial Agents and Chemotherapy, 2011
• In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
  Antimicrobial Agents and Chemotherapy, 2010
• Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs
  Bioorganic & Medicinal Chemistry Letters, 2010
• Reconsidering Some Approved Antimicrobial Agents for Tuberculosis
  Antimicrobial Agents and Chemotherapy, 2009
• Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes
  Journal of Antimicrobial Chemotherapy, 2005
• Synergy, antagonism, and what the chequerboard puts between them
  Journal of Antimicrobial Chemotherapy, 2003
• Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis
  Antimicrobial Agents and Chemotherapy, 2002